ReachMD

Be part of the knowledge.™

Nephrology

236

LikeLikedUnlike

Episodes 1-15 of 31

- Jürgen Floege, MD
  Peer
- Jonathan Barratt, PhD
  Peer
- David Jayne, MD
  Peer
0
CME/CE
Updates in Glomerular Disease
Updates in Glomerular Disease
0.50 credits
- Fouad T. Chebib, MD
  Peer
- Pranav S. Garimella, MD
  Peer
0
CME/CE
Case Management Strategies for Patients with ADPKD – Part 1
Case Management Strategies for Patients with ADPKD – Part 1
0.50 credits
- Martin Pollak, MD
  Peer
- Susanne Nicholas, MD, MPH, PhD
  Peer
2
CME/CE
Talking Rare: Epidemiology and Pathogenesis of APOL1-Mediated Kidney Disease
Talking Rare: Epidemiology and Pathogenesis of APOL1-Mediated Kidney Disease
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Stefan D. Anker, MD, PhD
  Peer
- Robert J. Mentz, MD, FHFSA, FACC, FAHA
  Peer
- Piotr Ponikowski, MD, PhD, FESC, FHFA
  Peer
5
CME/CE
Treating Iron Deficiency in Patients with HFrEF: A Review of the Recent Data for IV Iron Replacement Therapy
Treating Iron Deficiency in Patients with HFrEF: A Review of the Recent Data for IV Iron Replacement Therapy
0.50 credits
0
Advances in Chronic Kidney Disease
A Patient's Journey with ADPKD
A Patient's Journey with ADPKD
- Theodora A. Potretzke, MD
  Peer
- Fouad T. Chebib, MD
  Peer
2
CME/CE
Imaging in the Diagnosis and Management of ADPKD
Imaging in the Diagnosis and Management of ADPKD
0.50 credits
- Pam R. Taub, MD, FACC, FASPC
  Peer
- George L. Bakris, MD, FAHA, FASN
  Peer
- Gerasimos S. Filippatos, MD, FESC, FHFA, FHFSA(h)
  Peer
9
CME/CE
Reducing Morbidity and Mortality in Patients with CKD in T2D: New Late-Breaking Data
Reducing Morbidity and Mortality in Patients with CKD in T2D: New Late-Breaking Data
0.50 credits
- Piotr Ponikowski, MD, PhD, FESC, FHFA
  Peer
- Adrian F. Hernandez, MD, MHS
  Peer
- Professor Andrew Sindone
  Peer
8
CME/CE
What You Should Know When Addressing GDMT For ID in Heart Failure
What You Should Know When Addressing GDMT For ID in Heart Failure
0.25 credits
- Robert J. Mentz, MD, FHFSA, FACC, FAHA
  Peer
- Peter van der Meer, MD, PhD
  Peer
8
CME/CE
What Are We Missing? Iron Deficiency in Heart Failure
What Are We Missing? Iron Deficiency in Heart Failure
0.25 credits
- Neera Dahl, MD, PhD
  Peer
- Craig E. Gordon, MD
  Peer
3
CME/CE
Management of ADPKD
Management of ADPKD
0.50 credits
- Charles P. Vega, MD
  Peer
- Rajeev Raghavan, MD, M.Ed, FASN
  Peer
2
CME/CE
Improved Patient Outcomes Needed STAT! for Anemia in Chronic Kidney Disease
Improved Patient Outcomes Needed STAT! for Anemia in Chronic Kidney Disease
0.50 credits
- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Patrick Rossignol, MD, PhD
  Peer
17
CME/CE
Maximally Tolerated or Suboptimal Therapy? Clinical Perspectives on Rechallenging RAASi Therapy
Maximally Tolerated or Suboptimal Therapy? Clinical Perspectives on Rechallenging RAASi Therapy
0.25 credits
- Mikhail Kosiborod, MD
  Peer
24
CME/CE
Looking Beyond Diabetes: The Role of SGLT2i and MRAs in Cardiorenal Disease
Looking Beyond Diabetes: The Role of SGLT2i and MRAs in Cardiorenal Disease
0.25 credits
- Marco Metra, MD
  Peer
- Piotr Ponikowski, MD, PhD, FESC, FHFA
  Peer
8
CME/CE
Why Ischemia Matters When It Comes to Iron Deficiency in Heart Failure
Why Ischemia Matters When It Comes to Iron Deficiency in Heart Failure
0.25 credits
- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Stefan D. Anker, MD, PhD
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Bertram Pitt, MD
  Peer
16
CME/CE
The Role of Potassium Binders in Optimal HF Management: Discussing the DIAMOND Study
The Role of Potassium Binders in Optimal HF Management: Discussing the DIAMOND Study
0.25 credits

Program Chapters

Segment Chapters

Playlist:

Recommended